Remove Invest Remove IP Remove Study Remove UCLA
article thumbnail

Science37: Using Technology To Enable Remote, Clinical Trials, with Belinda Tan

socalTECH

The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures. Belinda Tan: Most of our trials are Phase 2 and Phase 3 studies.

article thumbnail

Pausing To Reflect: Veteran’s Day | Interview with Veteran and Tech Enthusiast Dustan Batton

Tech Zulu Event

After a short stint at a community college for some credits I needed, I was accepted to UCLA. MM: What did you study? Early on at UCLA I decided that I wanted to work on the political side of technology. It’s about the business community investing resources. I also received an academic scholarship for first year.